Continuous glucose monitors are about to get more complicated
Abbott has received FDA authorization for the Libre Duo, the first continuous glucose monitor capable of tracking both glucose and ketone levels. This development aims to provide better health insights for diabetic patients, though it adds complexity to device management.
Why it matters
Integrating ketone monitoring into wearable tech represents a significant advancement in personal health management for those at risk of diabetic ketoacidosis.
This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they’re going to change your life. Opt in for Optimizer here.
My mom was a dramatic woman prone to overreacting. When I was a snotty teen, I told her she needed to take several chill pills. Most of the time, I was right. Back in 2004, when she was swearing in Korean and hurtling down the highway in a Honda Odyssey that had no business going 20mph over the speed limit, swerving in and out of traffic as I vomited bile into a plastic baggie, I have to admit that she was right to rush me to the emergency room.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in